-
Partnering Program Works to Accelerate Parkinson’s Drug Development
January 29, 2014
… alleviate PD symptoms and mitigate the motor complications (dyskinesia) related to dopamine replacement therapy FPRT Bio … for pain management for the treatment of levodopa-induced dyskinesia and other hyperkinetic movement disorders To read …
-
Third Day of Congress Brings Focus to Parkinson’s Disease Clinical Research
June 20, 2012
… year. There is good news surrounding novel targets to treat dyskinesia that don’t necessarily have a dopamine-centric … hope, could reduce “off” time and “on” time without dyskinesia. People with Parkinson’s can struggle with … from a carbidopa patch designed to limit “off” time and dyskinesia. In the Neuroderm study, the patch was taken in …
-
Mariacristina Missale, PhD
… identification of molecular mechanisms of levodopa-induced dyskinesias in animal models of Parkinson‰Ûªs disease. … of these complexes in the development of levodopa-induced dyskinesias. …
-
Focused Ultrasound
… apart. This bilateral process treats motor symptoms and dyskinesia on both sides of the body. The bilateral … for Parkinson's-related tremor, stiffness or slowness and dyskinesia (uncontrolled, involuntary movement). In each … that aim to ease Parkinson’s movement symptoms or dyskinesia, as well as “off time” and motor fluctuations …
-
The Tolerability of Buspirone for the Treatment of Anxiety in Parkinson’s Disease
… additional potential benefit of reducing levodopa-induced dyskinesias, there are concerns that it could worsen motor … effects, anxiety, Parkinson’s disease motor function and dyskinesias will be evaluated. Impact on Diagnosis/Treatment …
-
Michael J. Fox Foundation Awards $1.1 Million for Validation of Parkinson’s Disease Therapeutic Targets
July 8, 2010
… focusing on targets that have the potential to alleviate dyskinesias, the excessive, uncontrollable movements … receptor gamma, as a potential target for treating dyskinesias. The possibility of providing evidence of the … mTORC1 as a Target for the Treatment of L-DOPA-induced Dyskinesia Gilberto Fisone, PhD, Karolinska Institutet, …